PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Finally, we found that the major risk PNPLA3 allele G for NAFLD was also associated with higher liver fibrosis stage and lower eGFR, thereby confirming observations from previous studies, showing the potential impact of this genetic polymorphism on the link between NAFLD and CKD (35).